Blood cancer Clinical Trials in Lake Success, NY
As of June 2026, 14 paid clinical trials are recruiting for Blood cancer in Lake Success, New York. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
14 clinical trials for Blood cancer
·Clear filters·↓ Download CSVA Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
About research studies in Lake Success
Lake Success has approximately 165 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in Lake Success
Researchers run research studies in Lake Success, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northwell Health/Center for Advanced Medicine | Stage IV Renal Cell Cancer AJCC v8, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 47 |
| Northwell Health | Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, 1st Line NSCLC | 19 |
| Northwell Health Cancer Institute | Acinar Cell Carcinoma, Advanced Cancer, Advanced Melanoma | 7 |
| Northwell Health/ RJ Zuckerberg Cancer Center | Neoplasm Metastasis, Advanced Solid Tumors, Carcinoma, Non-Small-Cell Lung | 6 |
| START New York | Advanced Solid Tumor, Advanced Solid Tumors, Endometrial Cancer | 4 |
| GSK Investigational Site | Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasms | 3 |
| Northwell Health, LLC PRIME | AML, AML With Mutated NPM1, Acute Leukemia | 3 |
| Northwell Health -The Arthur Smith Institute for Urology | Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 2 |
| Northwell Health Comprehensive Wound Healing Center | Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer), Vascular Disease, Peripheral, Venous Leg Ulcer (VLU) | 2 |
| Northwell Health Long Island Jewish Medical Center | Arterial Disease of Legs, Below-the-knee Obstruction, Chronic Limb-Threatening Ischemia | 2 |
| Northwell Health, R.J. Zuckerberg Cancer Center | Advanced Melanoma, MF, Myelofibrosis | 2 |
| RJ Zuckerberg | Colorectal Cancer Metastatic | 2 |
| Northwell Health - Monter Cancer Center | Non-Hodgkin Lymphoma, Non Small Cell Lung Cancer | 2 |
| Northwell Health Center for Advanced Medicine. | Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer | 2 |
| Clincial Research | Non-healing Wound, Venous Insufficiency of Leg, Venous Leg Ulcer | 1 |
| Clinical Research Alliance | Patients With Non-Small Cell Lung Cancer | 1 |
| Clinical Research Alliance, Inc | Small Cell Lung Cancer | 1 |
| Clinical Research Alliance, Inc. | Hematologic Malignancies | 1 |
| Cohen Children Medical Center | Vasculitis | 1 |
| Cohen Children's Medical Center | Cardiomyopathy | 1 |
| Cohen Children's Medical Center - Lakeville Road | Cystic Fibrosis | 1 |
| Cohen Children's Medical Center of NY | Crohn Disease | 1 |
| Cohen Children's Medical Center of New York | Rheumatic Joint Disease | 1 |
| Comprehensive Wound Healing Center, Northwell Health | Diabetic Foot Ulcer, Venous Leg Ulcer | 1 |
| Cynthia Knauer | Magnetic Resonance Imaging, Population at Risk, Prostate Cancer | 1 |
Active & Upcoming Studies in Lake Success (2026)
Recruiting trials in Lake Success grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (108 active studies)
- Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer · Phase 1 · Generate Biomedicines
- Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors · Phase 1 · Xencor, Inc.
Diabetes & metabolic (2 active studies)
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · Cleerly, Inc.
- DFC 004 Biomarkers for Active Diabetic Foot Ulcers · University of Michigan
Neurology & pain (2 active studies)
- Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS · Phase 2 · Vaneltix Pharma, Inc.
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Cardiovascular (2 active studies)
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation · Phase 3 · Novo Nordisk A/S
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Lake Success
- Advanced Solid Tumors (5 active studies). Recruiting Advanced Solid Tumors studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Endometrial Cancer (5 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non Small Cell Lung Cancer (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Acute Myeloid Leukemia (4 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Colorectal Cancer (4 active studies). Colorectal cancer trials explore novel chemotherapy combinations, targeted agents, and immunotherapy for microsatellite-instability-high tumors.
Leading research sponsors in Lake Success
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- AbbVie
- Bristol-Myers Squibb
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Lake Success. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Lake Success
Hipa.ai aggregates every recruiting study in Lake Success from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Lake Success?
There are approximately 165 recruiting clinical trials in Lake Success, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lake Success pay participants?
Most recruiting trials in Lake Success compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lake Success?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lake Success?
The most common conditions under active study in Lake Success include Advanced Solid Tumors (5), Endometrial Cancer (5), Non Small Cell Lung Cancer (5), Acute Myeloid Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lake Success?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lake Success on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lake Success?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lake Success?
Recruiting research sites in Lake Success include Northwell Health/Center for Advanced Medicine, Northwell Health, Northwell Health Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lake Success right now?
The largest active categories in Lake Success are Cancer & tumors (108), Diabetes & metabolic (2), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.